Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model

Neuroscience and Biobehavioral Reviews

Volumn 49, Issue , 2015, Pages 182-192

  Quintana, Daniel S ^a,b   Alvares, Gail A ^a   Hickie, Ian B ^a   Guastella, Adam J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Intranasal administration; Oxytocin; Social behavior; Social cognition

Indexed keywords

OXYTOCIN; PSYCHOTROPIC AGENT;

ABSORPTION; AMYGDALOID NUCLEUS; ANTISOCIAL PERSONALITY DISORDER; AUTISM; BIOLOGICAL MODEL; BLOOD BRAIN BARRIER; BRAIN STEM; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG MECHANISM; HUMAN; MENTAL DISEASE; NONHUMAN; OLFACTORY SYSTEM; PERIPHERAL NERVOUS SYSTEM; PREFRONTAL CORTEX; PROCESS OPTIMIZATION; REVIEW; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL COGNITION; SOMATOSENSORY SYSTEM; SYSTEMIC CIRCULATION; TRANQUILIZING ACTIVITY; TRIGEMINAL PATHWAY; ANATOMY AND HISTOLOGY; ANIMAL; COGNITION; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; NOSE;

ADMINISTRATION, INTRANASAL; ANIMALS; COGNITION; HUMANS; MODELS, BIOLOGICAL; NOSE; OXYTOCIN; PSYCHOTROPIC DRUGS; SOCIAL BEHAVIOR;

EID: 84920868879     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.12.011     Document Type: Review

References (138)

1. Aggarwal R., Cardozo A., Homer J. The assessment of topical nasal drug distribution. Clin. Otolaryngol. Allied Sci. 2004, 29:201-205.
2. Åkerlund M., Bossmar T., Brouard R., Kostrzewska A., Laudanski T., Lemancewicz A., Gal C.S.L., Steinwall M. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women. Br. J. Obstet. Gynaecol.: Int. J. Obstet. Gynaecol. 1999, 106:1047-1053.
3. Alvares G.A., Chen N.T.M., Balleine B.W., Hickie I.B., Guastella A.J. Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males. Psychoneuroendocrinology 2012, 37:2022-2031.
4. Anton F., Peppel P. Central projections of trigeminal primary afferents innervating the nasal mucosa: a horseradish peroxidase study in the rat. Neuroscience 1991, 41:617-628.
5. Bahadur S., Pathak K. Physicochemical and physiological considerations for efficient nose-to-brain targeting. Expert Opin. Drug Deliv. 2012, 9:19-31.
6. Baker H., Spencer R.F. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp. Brain Res. 1986, 63:461-473.
7. Bal E., Harden E., Lamb D., Van Hecke A.V., Denver J.W., Porges S.W. Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state. J. Autism Dev. Disord. 2010, 40:358-370.
8. Bales K.L., Perkeybile A.M., Conley O.G., Lee M.H., Guoynes C.D., Downing G.M., Yun C.R., Solomon M., Jacob S., Mendoza S.P. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol. Psychiatry 2013, 74:180-188.
9. Balin B.J., Broadwell R.D., Salcman M., el-Kalliny M. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J. Comp. Neurol. 1986, 251:260-280.
10. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cognitive Sci. 2011, 15:301-309.
11. Benelli A., Bertolini A., Poggioli R., Menozzi B., Basaglia R., Arletti R. Polymodal dose-response curve for oxytocin in the social recognition test. Neuropeptides 1995, 28:251-255.
12. Berntson G.G., Bigger J.T., Eckberg D.L., Grossman P., Kaufmann P.G., Malik M., Nagaraja H.N., Porges S.W., Saul J.P., Stone P.H., van der Molen M.W. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997, 34:623-648.
13. Bethlehem R.A.I., van Honk J., Auyeung B., Baron-Cohen S. Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies. Psychoneuroendocrinology 2013, 38:962-974.
14. Boccia M.L., Petrusz P., Suzuki K., Marson L., Pedersen C.A. Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience 2013, 253:155-164.
15. Brand G. Olfactory/trigeminal interactions in nasal chemoreception. Neurosci. Biobehav. Rev. 2006, 30:908-917.
16. Broadwell R.D., Balin B.J. Endocytic and exocytic pathways of the neuronal secretory process and trans synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo. J. Comp. Neurol. 1985, 242:632-650.
17. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68:815-834.
18. Buck L.B. The chemical senses. Principles of Neural Science 2000, 625-652. McGraw-Hill Companies, New York. E.R. Kandel, S.J.T.M. Jessell (Eds.).
19. Cacciotti-Saija C., Langdon R., Ward P.B., Hickie I.B., Scott E., Naismith S.L., Moore L., Alvares G.A., Reboblado-Hodge A., Guastella A.J. A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis. Schizophr. Bull.. 2014.
20. Cardoso C., Ellenbogen M.A., Orlando M.A., Bacon S.L., Joober R. Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology 2013, 38:399-407.
21. Cho M.M., DeVries A.C., Williams J.R., Carter C.S. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav. Neurosci. 1999, 113:1071.
22. Chow H.H.S., Chen Z., Matsuura G.T. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats. J. Pharm. Sci. 1999, 88:754-758.
23. Churchland P.S., Winkielman P. Modulating social behavior with oxytocin: how does it work? What does it mean?. Horm. Behav. 2012, 61:392-399.
24. Cifuentes M., Rodriguez S., Perez J. Decreased cerebrospinal fluid flow through the central canal of the spinal cord of rats immunologically deprived of Reissner's fibre. Exp. Brain Res. 1994, 98:431-440.
25. Ciriello J. Afferent renal inputs to paraventricular nucleus vasopressin and oxytocin neurosecretory neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1998, 275:R1745-R1754.
26. Conrad K.P., Gellai M., North W.G. Influence of oxytocin on renal hemodynamics and sodium excretion. Ann. N. Y. Acad. Sci. 1993, 689:346-362.
27. Danielyan L., Schäfer R., von Ameln-Mayerhofer A., Bernhard F., Verleysdonk S., Buadze M., Lourhmati A., Klopfer T., Schaumann F., Schmid B., Koehle C., Proksch B., Weissert R., Reichardt H.M., van den Brandt J., Buniatian G.H., Schwab M., Gleiter C.H., Frey I., William H. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res. 2011, 14:3-16.
28. Darlington D.N., Miyamoto M., Keil L.C., Dallman M.F. Paraventricular stimulation with glutamate elicits bradycardia and pituitary responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1989, 256:R112-R119.
29. De Dreu C.K.W., Greer L.L., Van Kleef G.A., Shalvi S., Handgraaf M.J.J. Oxytocin promotes human ethnocentrism. Proc. Natl. Acad. Sci. 2011, 108:1262-1266.
30. De Lorenzo A.J. Electron microscopic observations of the olfactory mucosa and olfactory nerve. J. Biophys. Biochem. Cytol. 1957, 3:839-850.
31. de Oliveira D.C., Zuardi A.W., Graeff F.G., Queiroz R.H., Crippa J.A. Anxiolytic-like effect of oxytocin in the simulated public speaking test. J. Psychopharmacol. (Oxf.) 2012, 26:497-504.
32. Declerck C.H., Boone C., Kiyonari T. Oxytocin and cooperation under conditions of uncertainty: the modulating role of incentives and social information. Horm. Behav. 2010, 57:368-374.
33. DeSesso J.M. The relevance to humans of animal models for inhalation studies of cancer in the nose and upper airways. Qual. Assur. 1993, 2:213-231. (San Diego, California).
34. Dhuria S.V., Hanson L.R., Frey W.H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 2010, 99:1654-1673.
35. Djupesland P.G. Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv. Transl. Res. 2012, 3:42-62.
36. Djupesland P.G., Messina J.C., Mahmoud R.A. The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview. Ther. Deliv. 2014, 5:709-733.
37. Djupesland P.G., Skretting A. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump. J. Aerosol Med. Pulm. Drug Deliv. 2012, 25:280-289.
38. Djupesland P.G., Skretting A., Winderen M., Holand T. Breath actuated device improves delivery to target sites beyond the nasal valve. Laryngoscope 2006, 116:466-472.
39. Domes G., Heinrichs M., Gläscher J., Büchel C., Braus D.F., Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 2007, 62:1187-1190.
40. Domes G., Heinrichs M., Michel A., Berger C., Herpertz S.C. Oxytocin improves mind-reading in humans. Biol. Psychiatry 2007, 61:731-733.
41. Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010, 35:83-93.
42. Ferris C., Foote K., Meltser H., Plenby M., Smith K., Insel T. Oxytocin in the amygdala facilitates maternal aggression. Ann. N. Y. Acad. Sci. 1992, 652:456-457.
43. Finger T.E., St Jeor V.L., Kinnamon J.C., Silver W.L. Ultrastructure of substance P- and CGRP-immunoreactive nerve fibers in the nasal epithelium of rodents. J. Comp. Neurol. 1990, 294:293-305.
44. Fjellestad-Paulsen A., Söderberg-Ahlm C., Lundin S. Metabolism of vasopressin, oxytocin, and their analogues in the human gastrointestinal tract. Peptides 1995, 16:1141-1147.
45. Gamer M., Schmitz A.K., Tittgemeyer M., Schilbach L. The human amygdala drives reflexive orienting towards facial features. Curr. Biol. 2013, 23:R917-R918.
46. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
47. Gordon I., Vander Wyk B.C., Bennett R.H. Oxytocin enhances brain function in children with autism. Proc. Natl. Acad. Sci. 2013, 110:20953-20959.
48. Grippo A.J., Trahanas D.M., Zimmerman R.R., Porges S.W., Carter C.S. Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 2009, 34:1542-1553.
49. Groppe S.E., Gossen A., Rademacher L., Hahn A., Westphal L., Gründer G., Spreckelmeyer K.N. Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain. Biol. Psychiatry 2013, 74:172-179.
50. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694.
51. Guastella A.J., Hickie I.B., McGuinness M.M., Otis M., Woods E.A., Disinger H.M., Chan H.-K., Chen T.F., Banati R.B. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology 2013, 38:612-625.
52. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P., Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 2009, 34:917-923.
53. Guastella A.J., MacLeod C. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Horm. Behav. 2012, 61:410-418.
54. Guastella A.J., Mitchell P.B., Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biol. Psychiatry 2008, 63:3-5.
55. Gumley A., Braehler C., Macbeth A. A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery. Br. J. Clin. Psychol. 2014, 53:42-61.
56. Gutkowska J., Jankowski M. Oxytocin revisited: its role in cardiovascular regulation. J. Neuroendocrinol. 2012, 24:599-608.
57. Gutkowska J., Jankowski M., Lambert C., Mukaddam-Daher S., Zingg H.H., McCann S.M. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc. Natl. Acad. Sci. 1997, 94:11704-11709.
58. Hall S.S., Lightbody A.A., McCarthy B.E., Parker K.J., Reiss A.L. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology 2012, 37:509-518.
59. Hashizume R., Ozawa T., Gryaznov S.M., Bollen A.W., Lamborn K.R., Frey W.H., Deen D.F. New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol. 2008, 10:112-120.
60. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
61. Higa K.T., Mori E., Viana F.F., Morris M., Michelini L.C. Baroreflex control of heart rate by oxytocin in the solitary-vagal complex. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R537-R545.
62. Higgins C.B., Vatner S.F., Braunwald E. Parasympathetic control of the heart. Pharmacol. Rev. 1973, 25:119-155.
63. Hollander E., Bartz J., Chaplin W., Phillips A., Sumner J., Soorya L., Anagnostou E., Wasserman S. Oxytocin increases retention of social cognition in autism. Biol. Psychiatry 2007, 61:498-503.
64. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and asperger's disorders. Neuropsychopharmacology 2003, 28:193-198.
65. Ignashchenkova A., Dicke P.W., Haarmeier T., Thier P. Neuron-specific contribution of the superior colliculus to overt and covert shifts of attention. Nat. Neurosci. 2003, 7:56-64.
66. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 2007, 56:27-78.
67. Illum L. Nasal delivery. The use of animal models to predict performance in man. J. Drug Target 1996, 3:427-442.
68. Irngartinger M., Camuglia V., Damm M., Goede J., Frijlink H.W. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing. Eur. J. Pharm. Biopharm. 2004, 58:7-14.
69. Jansson B., Björk E. Visualization of in vivo olfactory uptake and transfer using fluorescein dextran. J. Drug Target 2002, 10:379-386.
70. Johnson N.J., Hanson L.R., Frey I., William H. Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol. Pharm. 2010, 7:884-893.
71. Jolkkonen E., Miettinen R., Pitkänen A. Projections from the amygdalo-piriform transition area to the amygdaloid complex: a PHA-l study in rat. J. Comp. Neurol. 2001, 432:440-465.
72. Kang N., Baum M.J., Cherry J.A. Different profiles of main and accessory olfactory bulb mitral/tufted cell projections revealed in mice using an anterograde tracer and a whole-mount, flattened cortex preparation. Chem. Senses 2011, 36:251-260.
73. Kaur P., Kim K. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits. Int. J. Pharm. 2008, 364:27-35.
74. Kemp A.H., Guastella A.J. The role of oxytocin in human affect a novel hypothesis. Curr. Dir. Psychol. Sci. 2011, 20:222-231.
75. Kemp A.H., Quintana D.S., Kuhnert R.-L., Griffiths K., Hickie I.B., Guastella A.J. Oxytocin increases heart rate variability in humans at rest: implications for social approach-related motivation and capacity for social engagement. PLoS One 2012, 7:e44014.
76. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 25:11489-11493.
77. Labuschagne I., Phan K.L., Wood A., Angstadt M., Chua P., Heinrichs M., Stout J.C., Nathan P.J. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010, 35:2403-2413.
78. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
79. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 1988, 8:2517-2529.
80. Liu Q., Shen Y., Chen J., Gao X., Feng C., Wang L., Zhang Q., Jiang X. Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles. Pharm. Res. 2012, 29:546-558.
81. Lochhead J.J., Thorne R.G. Intranasal delivery of biologics to the central nervous system. Adv. Drug Deliv. Rev. 2012, 64:614-628.
82. MacDonald E., Dadds M.R., Brennan J.L., Williams K., Levy F., Cauchi A.J. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology 2011, 36:1114-1126.
83. MacDonald K., Feifel D. Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. Acta Neuropsychiatr. 2012, 24:130-146.
84. MacDonald K., Feifel D. Oxytocin's role in anxiety: a critical appraisal. Brain Res. 2014.
85. Manning M., Misicka A., Olma A., Bankowski K., Stoev S., Chini B., Durroux T., Mouillac B., Corbani M., Guillon G. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J. Neuroendocrinol. 2012, 24:609-628.
86. Meddle S.L., Leng G., Selvarajah J.R., Bicknell R.J., Russell J.A. Direct pathways to the supraoptic nucleus from the brainstem and the main olfactory bulb are activated at parturition in the rat. Neuroscience 2000, 101:1013-1021.
87. Meyer-Lindenberg A. Impact of prosocial neuropeptides on human brain function. Prog. Brain Res. 2008, 170:463-470.
88. Modi M.E., Young L.J. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies. Horm. Behav. 2012, 61:340-350.
89. Mori I., Goshima F., Ito H., Koide N., Yoshida T., Yokochi T., Kimura Y., Nishiyama Y. The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus. Virology 2005, 334:51-58.
90. Morrison E.E., Costanzo R.M. Morphology of olfactory epithelium in humans and other vertebrates. Microsc. Res. Tech. 1992, 23:49-61.
91. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35:649-659.
92. Neumann I.D., Maloumby R., Beiderbeck D.I., Lukas M., Landgraf R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 2013, 38:1985-1993.
93. Nonaka N., Farr S.A., Kageyama H., Shioda S., Banks W.A. Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins. J. Pharmacol. Exp. Ther. 2008, 325:513-519.
94. Norman G.J., Cacioppo J.T., Morris J.S., Malarkey W.B., Berntson G.G., DeVries A.C. Oxytocin increases autonomic cardiac control: moderation by loneliness. Biol. Psychol. 2011, 86:174-180.
95. Perez-Rodriguez M.M., Derish N.E., New A.S. The use of oxytocin in personality disorders: rationale and current status. Curr. Treat. Options Psychiatry 2014, 1:345-357.
96. Perez-Rodriguez M.M., Mahon K., Russo M., Ungar A.K., Burdick K.E. Oxytocin and social cognition in affective and psychotic disorders. Eur. Neuropsychopharmacol. 2014.
97. Petersson M., Alster P., Lundeberg T., Uvnäs-Moberg K. Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol. Behav. 1996, 60:1311-1315.
98. Petersson M., Uvnäs-Moberg K. Postnatal oxytocin treatment of spontaneously hypertensive male rats decreases blood pressure and body weight in adulthood. Neurosci. Lett. 2008, 440:166-169.
99. Petrovic P., Kalisch R., Singer T., Dolan R.J. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J. Neurosci. 2008, 28:6607-6615.
100. Popik P., Vetulani J., Van Ree J.M. Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology 1992, 106:71-74. (Berlin).
101. Popp J.A., Monteiro-Riviere N.A. Macroscopic, microscopic, and ultrastructural anatomy of the nasal cavity, rat. Respiratory System 1985, 3-10. Springer-Verlag, Berlin.
102. Porges S.W. The Polyvagal Theory: Neurophysiological Foundations of Emotions, Attachment, Communication, and Self-regulation 2011, W.W. Norton & Company, New York. 1st ed.
103. Price J.L. An autoradiographic study of complementary laminar patterns of termination of afferent fibers to the olfactory cortex. J. Comp. Neurol. 1973, 150:87-108.
104. Quintana D.S., Guastella A.J., Outhred T., Hickie I.B., Kemp A.H. Heart rate variability is associated with emotion recognition: direct evidence for a relationship between the autonomic nervous system and social cognition. Int. J. Psychophysiol. 2012, 86:168-172.
105. Quintana D.S., Kemp A.H., Alvares G.A., Guastella A.J. A role for autonomic cardiac control in the effects of oxytocin on social behavior and psychiatric illness. Front. Neurosci. 2013, 7:1-9.
106. Quirin M., Kuhl J., Düsing R. Oxytocin buffers cortisol responses to stress in individuals with impaired emotion regulation abilities. Psychoneuroendocrinology 2011, 36:898-904.
107. Reiss C.S., Plakhov I.V., Komatsu T. Viral replication in olfactory receptor neurons and entry into the olfactory bulb and brain. Ann. N. Y. Acad. Sci. 1998, 855:751-761.
108. Riem M.M., van IJzendoorn M.H., Tops M., Boksem M.A., Rombouts S.A., Bakermans-Kranenburg M.J. Oxytocin effects on complex brain networks are moderated by experiences of maternal love withdrawal. Eur. Neuropsychopharmacol. 2013, 23:1288-1295.
109. Rogers R.C., Hermann G.E. Hypothalamic paraventricular nucleus stimulation-induced gastric acid secretion and bradycardia suppressed by oxytocin antagonist. Peptides 1986, 7:695-700.
110. Roldan-Valadez E., Martinez-Anda J.J., Corona-Cedillo R. 3T MRI and 128-slice dual-source CT cisternography images of the cranial nerves a brief pictorial review for clinicians. Clin. Anat. 2014, 27:31-45.
111. Ross C.A., Ruggiero D.A., Joh T.H., Park D.H., Reis D.J. Adrenaline synthesizing neurons in the rostral ventrolateral medulla: a possible role in tonic vasomotor control. Brain Res. 1983, 273:356-361.
112. Ross T.M., Zuckermann R.N., Reinhard C., Frey I.I.W.H. Intranasal administration delivers peptoids to the rat central nervous system. Neurosci. Lett. 2008, 439:30-33.
113. Saha S. Role of the central nucleus of the amygdala in the control of blood pressure: descending pathways to medullary cardiovascular nuclei. Clin. Exp. Pharmacol. Physiol. 2005, 32:450-456.
114. Sartain J.B., Barry J.J., Howat P.W., McCormack D.I., Bryant M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. Br. J. Anaesth. 2008, 101:822-826.
115. Schaefer M.L., Böttger B., Silver W.L., Finger T.E. Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli. J. Comp. Neurol. 2002, 444:221-226.
116. Sereno A.B., Briand K.A., Amador S.C., Szapiel S.V. Disruption of reflexive attention and eye movements in an individual with a collicular lesion. J. Clin. Exp. Neuropsychol. 2006, 28:145-166.
117. Shahrokh D.K., Zhang T.Y., Diorio J., Gratton A., Meaney M.J. Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 2010, 151:2276-2286.
118. Shamay-Tsoory S.G. One hormonal system for love and envy: a reply to tops. Biol. Psychiatry 2010, 67:e7.
119. Shamay-Tsoory S.G., Fischer M., Dvash J., Harari H., Perach-Bloom N., Levkovitz Y. Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biol. Psychiatry 2009, 66:864-870.
120. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
121. Sofroniew M.V., Schrell U. Evidence for a direct projection from oxytocin and vasopressin neurons in the hypothalamic paraventricular nucleus to the medulla oblongata: immunohistochemical visualization of both the horseradish peroxidase transported and the peptide produced by the same neurons. Neurosci. Lett. 1981, 22:211-217.
122. Sosulski D.L., Bloom M.L., Cutforth T., Axel R., Datta S.R. Distinct representations of olfactory information in different cortical centres. Nature 2012, 472:213-216.
123. Stoeckel M.E., Freund-Mercier M.J. Autoradiographic localization of binding sites for oxytocin and vasopressin in the rat kidney. J. Endocrinol. 1987, 113:179-182.
124. Thayer J.F. Heart rate variability: a neurovisceral integration model. Encyclopedia of Neuroscience 2009, 1041-1047. Academic Press, Oxford. L.R. Squire (Ed.).
125. Thayer J.F., Lane R.D. Claude Bernard and the heart-brain connection: further elaboration of a model of neurovisceral integration. Neurosci. Biobehav. Rev. 2009, 33:81-88.
126. Thomas J.S., Koh S.H., Cooper G.M. Haemodynamic effects of oxytocin given as I.V. bolus or infusion on women undergoing Caesarean section. Br. J. Anaesth. 2007, 98:116-119.
127. Thorne R.G., Pronk G.J., Padmanabhan V., Frey I.W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004, 127:481-496.
128. Usunoff K.G., Marani E., Schoen J.H. The trigeminal system in man. Adv. Anat. Embryol. Cell Biol. 1997, 136:1-118.
129. Van IJzendoorn M.H., Bhandari R., Van der Veen R., Grewen K.M., Bakermans-Kranenburg M.J. Elevated salivary levels of oxytocin persist more than 7h after intranasal administration. Front. Neurosci. 2012, 6.
130. Veening J.G., Olivier B. Intranasal administration of oxytocin: behavioral and clinical effects, a review. Neurosci. Biobehav. Rev. 2013, 37:1445-1465.
131. Viviani D., Charlet A., van den Burg E., Robinet C., Hurni N., Abatis M., Magara F., Stoop R. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 2011, 333:104-107.
132. Williams L.S., Schmalfuss I.M. MR imaging of the trigeminal ganglion, nerve, and the perineural vascular plexus: normal appearance and variants with correlation to cadaver specimens. Am. J. Neuroradiol. 2003, 24:1317-1323.
133. Windle R., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.
134. Wittfoth-Schardt D., Gründing J., Wittfoth M., Lanfermann H., Heinrichs M., Domes G., Buchheim A., Gündel H., Waller C. Oxytocin modulates neural reactivity to children's faces as a function of social salience. Neuropsychopharmacology 2012, 37:1799-1807.
135. Wolburg H., Wolburg-Buchholz K., Sam H., Horvát S., Deli M.A., Mack A.F. Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat. Histochem. Cell Biol. 2008, 130:127-140.
136. Yang J.-P., Liu H.-J., Cheng S.-M., Wang Z.-L., Cheng X., Yu H.-X., Liu X.-F. Direct transport of VEGF from the nasal cavity to brain. Neurosci. Lett. 2009, 449:108-111.
137. Young L.J., Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 2004, 7:1048-1054.
138. Yu G.Z., Kaba H., Okutani F., Takahashi S., Higuchi T. The action of oxytocin originating in the hypothalamic paraventricular nucleus on mitral and granule cells in the rat main olfactory bulb. Neuroscience 1996, 72:1073-1082.